ALEC - Alector, Inc.
2
-0.120 -6.000%
Share volume: 466,465
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.12
-0.12
-0.06%
Summary score
35%
Profitability
35%
Dept financing
39%
Liquidity
47%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2021 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
0%
Return on assets
-6.02%
Return on sales
-399.7%
Return on invested capital
0%
Total debt ratio
75.54%
Debt ratio change over timeo
-0.03%
Current Ratio
4.48%
Quick Ratio
0%
Cash Position Ratio
0.95%
Short-term ratios 31-Dec-2024 - 31-Dec-2025
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-10.37%
Return on sales
-859.52%
Return on invested capital
0%
Total debt ratio
82.3%
Debt ratio change over timeo
0%
Current Ratio
3.68%
Quick Ratio
0%
Cash Position Ratio
0.7%
Last quarter ratios 31-Dec-2025
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-12.65%
Return on sales
-634.38%
Return on invested capital
0%
Total debt ratio
89.55%
Debt ratio change over time
0%
Current Ratio
3.83%
Quick Ratio
0%
Cash Position Ratio
0.95%
Performance ratios (change over 4 years) 31-Dec-2021 - 31-Dec-2025
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
-106.17%
Return on sales
-341.89%
Return on invested capital
0%
Total debt ratio
-3.44%
Debt ratio change over time
-0.03%
Current Ratio
7.37%
Quick Ratio
0%
Cash Position Ratio
3.27%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | ALEC | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 5.97% | 8.91% |
| Return on assets | -6.02% | 2.97% | 3.34% | 2.04% |
| Return on sales | -399.7% | 27.71% | 27.82% | 21.49% |
| Return on invested capital | 0% | 0% | 3.51% | 10.25% |
| Profitability | 0% | 47% | 75% | 85% |
| Total debt ratio | 75.54% | 93.27% | 65.75% | 43.64% |
| Debt ratio change over time | -0.03% | 14.34% | 187.33% | 9.75% |
| Dept financing | 20% | 27% | 43% | 13% |
| Current Ratio | 3.68% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 0.7% | 0.39% | 0.58% | 0.86% |
| Liquididy | 50% | 49% | 39% | 56% |
| Short-term ratios | ALEC | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | 0% |
| Return on assets | -10.37% | 3.27% | 4.7% | 1.36% |
| Return on sales | -859.52% | 24.35% | 34.09% | 15.11% |
| Return on invested capital | 0% | 0% | 0% | 0% |
| Profitability | 50% | 35% | 50% | 18% |
| Total debt ratio | 82.3% | 91.09% | 63.87% | 38.21% |
| Debt ratio change over time | 0% | 0% | 0% | 0% |
| Dept financing | 48% | 25% | 18% | 10% |
| Current Ratio | 3.68% | 1.22% | 1.42% | 2.33% |
| Quick Ratio | 0% | 0.94% | 1.27% | 1.72% |
| Cash Position Ratio | 0.7% | 0.39% | 0.58% | 0.86% |
| Liquididy | 45% | 33% | 45% | 66% |